Australia markets closed

G1 Therapeutics, Inc. (GTHX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.4900+0.0500 (+1.13%)
At close: 04:00PM EDT
4.4900 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 234.85M
Enterprise value 208.59M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.82
Price/book (mrq)6.64
Enterprise value/revenue 2.53
Enterprise value/EBITDA -6.08

Trading information

Stock price history

Beta (5Y monthly) 1.70
52-week change 352.05%
S&P500 52-week change 322.38%
52-week high 35.0000
52-week low 31.0800
50-day moving average 33.8526
200-day moving average 32.6491

Share statistics

Avg vol (3-month) 31.18M
Avg vol (10-day) 3585.66k
Shares outstanding 552.3M
Implied shares outstanding 652.3M
Float 843.87M
% held by insiders 111.66%
% held by institutions 130.02%
Shares short (15 Apr 2024) 42.42M
Short ratio (15 Apr 2024) 42.73
Short % of float (15 Apr 2024) 44.67%
Short % of shares outstanding (15 Apr 2024) 44.63%
Shares short (prior month 15 Mar 2024) 42.69M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -36.40%
Operating margin (ttm)-62.50%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)84.04M
Revenue per share (ttm)1.62
Quarterly revenue growth (yoy)11.80%
Gross profit (ttm)N/A
EBITDA -22.32M
Net income avi to common (ttm)-30.59M
Diluted EPS (ttm)-0.9300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)82.16M
Total cash per share (mrq)1.57
Total debt (mrq)57.17M
Total debt/equity (mrq)161.57%
Current ratio (mrq)N/A
Book value per share (mrq)0.68

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A